Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Apr 25 2024 12:00
    74,339.44 +486.50 ( +0.66%)
  • NIFTY Apr 25 2024 12:00
    22,570.35 +167.95 ( +0.75%)
  • SENSEX Apr 25 2024 12:00
    74,339.44 +486.50 ( +0.66%)
  • NIFTY Apr 25 2024 12:00
    22,570.35 +167.95 ( +0.75%)
  • Nasdaq Apr 25 2024 04:30
    15,712.75 +16.11 ( +0.10%)
  • DJIA Apr 25 2024 04:30
    38,460.92 -42.77 (-0.11%)
  • S&P 500 Apr 25 2024 04:30
    5,071.63 +1.08 ( +0.02%)
  • Hang Seng Apr 25 2024 02:10
    17,284.54 +83.27 ( +0.48%)
  • Crude Oil Apr 25 2024 07:30
    6,884.00 -5.00 (-0.07%)
  • Gold Apr 25 2024 07:30
    70,931.00 -119.00 (-0.17%)
  • Silver Apr 25 2024 07:30
    80,455.00 -42.00 (-0.05%)
  • Copper Apr 25 2024 07:24
    847.10 +4.00 ( +0.47%)
  • Pound / Rupee Dec 23 2016 22:30
    103.28 +0.27 ( +0.26%)
  • Dollar / Rupee Dec 23 2016 22:30
    83.31 -0.07 (-0.09%)
  • Euro / Rupee Dec 23 2016 22:30
    88.96 +0.13 ( +0.14%)
  • Yen / Rupee Dec 23 2016 22:30
    0.54 0.00 (-0.11%)

Fairchem Organics Ltd

BSE Code : 543252 | NSE Symbol : FAIRCHEMOR | ISIN:INE0DNW01011| SECTOR : Chemicals |

NSE BSE
 
SMC up arrow

1,398.55

11.80 (0.85%) Volume 24046

25-Apr-2024 EOD

Prev. Close

1,386.75

Open Price

1,392.00

Bid Price (QTY)

1,398.55(5)

Offer Price (QTY)

0.00(0)

 

Today’s High/Low 1,419.90 - 1,382.00

52 wk High/Low 1,528.80 - 999.00

Key Stats

MARKET CAP (RS CR) 1794.87
P/E 44.21
BOOK VALUE (RS) 204.2345469
DIV (%) 75
MARKET LOT 1
EPS (TTM) 31.18
PRICE/BOOK 6.74934784992538
DIV YIELD.(%) 0.54
FACE VALUE (RS) 10
DELIVERABLES (%) 56.64
4

News & Announcements

08-Apr-2024

Fairchem Organics Ltd - Fairchem Organics Limited - Certificate from Debenture Trustee

03-Apr-2024

Fairchem Organics Ltd - Fairchem Organics Limited - Disclosure under SEBI Takeover Regulations

22-Mar-2024

Fairchem Organics Ltd - Fairchem Organics Limited - Trading Window

22-Mar-2024

Fairchem Organics Ltd - Fairchem Organics Limited - Trading Window

07-Feb-2024

Fairchem Organics to conduct EGM

16-Jan-2024

Fairchem Organics announces board meeting date

16-Oct-2023

Fairchem Organics to discuss results

31-Jul-2023

Fairchem Organics receives affirmation in credit ratings

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Aarti Industries Ltd 524208 AARTIIND
Aarti Surfactants Ltd 543210 AARTISURF
Aarti Surfactants Ltd Partly Paidup 890180 AARTIPP
Absolute Aromatics Ltd 40209
Aditya Info-Soft Ltd 530693
Advance Petrochemicals Ltd 506947
Aether Industries Ltd 543534 AETHER
Alang Industrial Gases Ltd 531517
Alkali Metals Ltd 533029 ALKALI
Alkyl Amines Chemicals Ltd 506767 ALKYLAMINE
Allied Resins & Chemicals Ltd(merged) 524538 ALLIEDRES
Alufluoride Ltd 524634
Amal Ltd 506597
Ambani Organics Ltd 535097 AMBANIORG
Ambica Agarbathies Aroma & Industries Ltd 532335 AMBICAAGAR
Amex Carbonates & Chemicals Ltd 531321
Amines & Plasticizers Ltd 506248 AMNPLST
Aminex Chemicals Ltd (Wound-up) 524386
Amit Alcohol & Carbon Dioxide Ltd (Merged) 506904
Anan Drug & Chem Ltd 531999
Andhra Petrochemicals Ltd 500012 ANDHRAPET
Anjana Explosives Ltd 40329
Anupam Rasayan India Ltd 543275 ANURAS
Arabian Petroleum Ltd 77164 ARABIAN
Archean Chemical Industries Ltd 543657 ACI
Archit Organosys Ltd 524640
ARCL Organics Ltd 543993
Arvee Laboratories (India) Ltd 535050 ARVEE
Arvin Liquid Gases Ltd 523404
Asiatic Oxygen Ltd 40030
Atul Ltd 500027 ATUL
Avikem Resins Ltd 523784
B L Industries (India) Ltd 530637
Balaji Amines Ltd 530999 BALAMINES
Barium Chemcials Ltd 506275
Baroda Carbons Ltd 523527
BASF India Ltd 500042 BASF
Benzo Petro International Ltd 524737
Benzo Petrochemicals Ltd (Wound Up) 524196
Bhagawati Gas Ltd 500051 BAGWATIGAS
Bhagawati Oxygen Ltd 509449
Bhatia Colour Chem Ltd 543497
Bhuruka Gases Ltd 509728
Bhuvan Tripura Industries Ltd 524725
Binaca Synthetic Resins Ltd 514344
Borax Morarji Ltd(Merged) 506315
Burmah Petro Products Ltd 40310
C J Gelatine Products Ltd 507515
Cabot India Ltd 506700 CABOTINDIA
Camlin Fine Sciences Ltd 532834 CAMLINFINE
Canvay Chemicals Ltd 531535
Caprolactam Chemicals Ltd 507486
Carbon & Chemicals India Ltd (Merged) 505813
Castrol India Ltd 500870 CASTROLIND
Cellulose Products of India Ltd 506345
Chembond Chemicals Ltd 530871 CHEMBOND
Chemcon Speciality Chemicals Ltd 543233 CHEMCON
Chemcrux Enterprises Ltd 540395
Chemfab Alkalis Ltd 541269 CHEMFAB
Chemiesynth (Vapi) Ltd 539230
Chemplast Sanmar Ltd 543336 CHEMPLASTS
Chimique Laboratories (India) Ltd 40300
Ciba India Ltd(merged) 532184 CIBASPEC
Cilson Organics Ltd 532147
Citric India Ltd 506370
Citurgia Biochemicals Ltd 506373 CITURGIBIO
Clariant (India) Ltd(merged) 500373 CLARIANT
Clarisis Organics Ltd 524806
Claro India Ltd 524366
Clean Science & Technology Ltd 543318 CLEAN
Cochin Minerals & Rutile Ltd 513353
Continental Petroleums Ltd 523232
Core Organics Ltd 524466
Crestchem Ltd 526269
Dai-ichi Karkaria Ltd 526821 DAICHIKARK
DDev Plastiks Industries Ltd 543547
Deccan Petroleums Ltd 526375
Deepak Fertilizers & Petrochemicals Corp Ltd 500645 DEEPAKFERT
Deepak Nitrite Ltd 506401 DEEPAKNTR
Diamines & Chemicals Ltd 500120 DIAMINESQ
DIC India Ltd 500089 DICIND
Diviya Chemicals Ltd 506810
DMCC Speciality Chemicals Ltd 506405 DMCC
Doctors Biotech India Ltd 512079
Dujodwala Paper Chemicals Ltd 524276
Eiko Lifesciences Ltd 540204
Eiko Lifesciences Ltd Partly Paidup 890189
Elantas Beck India Ltd 500123 DRBECK
Ellenbarrie Industrial Gases Ltd 590087
Emmessar Biotech & Nutrition Ltd 524768
EPIC Enzymes Pharma & Industrial Chemicals Ltd 524374
Ficom Organics Ltd(merged) 506443 FICOMORGAN
Fine Organic Industries Ltd 541557 FINEORG
Fineotex Chemical Ltd 533333 FCL
Foseco India Ltd 500150 FOSECOIND
Futuristic Offshore Services and Chemical Ltd 500154 GANESHANHY
Gagan Gases Ltd 524624
Galaxy Oleo-Chem (India) Ltd 40207
Galaxy Surfactants Ltd 540935 GALAXYSURF
GBL Industries Ltd 539009
GHCL Ltd 500171 GHCL
Glory Chemicals Ltd 531532
GOCL Corporation Ltd 506480 GOCLCORP
Godrej Industries Ltd 500164 GODREJIND
Goiex Michio Sudo Ltd 507978
GOM Industries Ltd 523802
Goodearth Industries Ltd 526929
Goodearth Organic (India) Ltd [Wound-up] 524300
Govind Poy Oxygen Ltd 509586
GP Petroleums Ltd 532543 GULFPETRO
Grauer & Weil (India) Ltd 505710 GRAUWEIL
Gresoil (India) Ltd 530483
Gujarat Carbon & Industries Ltd 506457
Gujarat Fluorochemicals Ltd 542812 FLUOROCHEM
Gujarat Indo-Lube Ltd 523552
Gujarat Narmada Valley Fertilizers & Chemicals Ltd 500670 GNFC
Gujarat Oiland Industries Ltd (Wound Up) 507866
Gujarat Organics Ltd 501368
Gujarat Speciality Lubes Ltd 523880
Gulf Oil India Ltd - Merged 511026 GULFOIL
Gulf Oil Lubricants India Ltd 538567 GULFOILLUB
Gulshan Sugars & Chemicals Ltd(merged) 524184
Haryana Leather Chemicals Ltd 524080
Hemo Organic Ltd 524590
Hico Products Ltd 506461
Hi-Green Carbon Ltd 91663 HIGREEN
Hilltone Industrial Gases Ltd 40441
Himadri Speciality Chemical Ltd 500184 HSCL
Hindcon Chemicals Ltd 535053 HINDCON
Hindustan Industrial Chemicals Ltd 524679 HINDINDCHM
Hindustan Organic Chemicals Ltd 500449 HOCL
Hindustan Oxygen Gas Ltd 509660
HP Adhesives Ltd 543433 HPAL
Hubergroup India Pvt Ltd 523886 MICRO
I G Petrochemicals Ltd 500199 IGPL
IBP Co. Ltd(merged) 500198 IBP
Iccon Oil & Specialities Ltd 523766
India Carbon Ltd 40012
India Gelatine & Chemicals Ltd 531253
Indian Electro Chemicals Ltd 506490
Indo Amines Ltd 524648 INDOAMIN
Indo Borax & Chemicals Ltd 524342 INDOBORAX
Indo Gulf Industries Ltd 506945
Indo Vanillon Chemicals Ltd 531267
Indu Nissan Oxo Chemicals Industries Ltd 500208 INDUNISSAN
Inox Air Products Pvt Ltd 526534 INDOXYGEN
Insilco Ltd 500211 INSILCO
Iota Chemiculture Ltd(Liquidated) 524630
IVP Ltd 507580 IVP
J F Laboratories Ltd 523804 JFLABS
J.G.Chemicals Ltd 544138 JGCHEM
J.R. Organics Ltd 506650
Jay Agrochem Ltd (Wound Up) 513504
Jayant Agro Organics Ltd 524330 JAYAGROGN
Jocil Ltd 500561 JOCIL
Jubilant Industries Ltd 533320 JUBLINDS
Jubilant Ingrevia Ltd 543271 JUBLINGREA
Jyoti Resins and Adhesives Ltd 514448
K P Gelatines & Chemicals India Ltd (Wound-up) 524741
Kamar Chemicals & Industries Ltd 531001
Kanchi Karpooram Ltd 538896
Kanoria Chemicals & Industries Ltd 506525 KANORICHEM
Kanva Hydro Chem Ltd 524685
Karnataka Chemical Industries Corp Ltd 530105
Karnav Leather Chemicals Ltd 524432
Keltech Energies Ltd 506528
Kesar Petroproducts Ltd 524174
Kilburn Chemicals Ltd 524699
Kings India Chemicals Corporation Ltd 524214
Kothari Polymers Ltd 40360
Krishna Plastochem Ltd (Wound Up) 524254
Laxmi Organic Industries Ltd 543277 LXCHEM
Lime Chemicals Ltd 507759
Linde India Ltd 523457 LINDEINDIA
Link Pharma Chem Ltd 524748
Lords Chemicals Ltd 530039
M.P. Carbide & Chemicals Ltd 506925
Madras Petrochem Ltd 500261
Maha Chemicals Ltd (Wound-up) 524556
Maharashtra Explosives Ltd (Wound-up) 506871
Maharashtra Polybutenes Ltd 524232
Mangalam Organics Ltd 514418 MANORG
Mark Omega Organic Industries Ltd 524681
Maruti Industrial Carbohydrates Ltd 524814
Maruti Organics Ltd 524402 MARUTIORNG
Master Chemicals Ltd 506867
Mehta Rubber Chemcials Ltd 526536
Mehta Sulfites (India) Ltd 530029
mk Aromatics Ltd 531011
Motorol (I) Ltd 508965 MOTOROL
Motorol Enterprises Ltd 523049 RINKIPETRO
Motorol Speciality Oils Ltd 506954
MTZ Industries Ltd 500275 METAZINC
Murablack India Ltd 523578 MURABLACK
Nacro Chemicals Ltd 524350
Nariman Point Chemical Industries Ltd 524224
Narmada Gelatines Ltd 526739 SHAWGELTIN
National Oxygen Ltd 507813 NOL
Navin Fluorine International Ltd 532504 NAVINFLUOR
Neogen Chemicals Ltd 542665 NEOGEN
Newton Engineering & Chemicals Ltd 524474
Nikhil Adhesives Ltd 526159
Niraj Petrochemicals Ltd 500454 NIRAJPETRO
Nitta Gelatin India Ltd 506532 KERALACHEM
NLC Nalco India Ltd 524101 NALCOCHEM
Noble Explochem Ltd 506991
NOCIL Ltd 500730 NOCIL
Nouryon Chemical India Pvt Ltd 500082 CENTAKCHEM
Nova Chemie (India) Ltd 40188
Ojas Technochem Products Ltd(wound-up) 526427
Omkar Speciality Chemicals Ltd 533317 OMKARCHEM
Organic Coatings Ltd 531157
Orient Organics Ltd 524766
Oriental Aromatics Ltd 500078 OAL
Oriental Carbon & Chemicals Ltd 506579 OCCL
Orissaa Organics Ltd 524392
Oswali Chemicals Ltd 506916
Padmanabh Industries Ltd 526905
Paintex Chemicals (Bombay) Ltd 524178
Paragon Fine and Speciality Chemical Ltd 91901 PARAGON
Paschim Petrochem Ltd 531005
Paushak Ltd 532742
PCBL Ltd 506590 PCBL
Pentasia Chemicals Ltd (Merged) 507739
Pidilite Industries Ltd 500331 PIDILITIND
Pinky Chemicals Ltd 524671
Plastiblends India Ltd 523648 PLASTIBLEN
Platinum Industries Ltd 544134 PLATIND
Polyolefins Industries Ltd (Merged) 506610
Premier Explosives Ltd 526247 PREMEXPLN
Privi Speciality Chemicals Ltd 530117 PRIVISCL
Protchem Industries (India) Ltd 524117
Rain Calcining Ltd(merged) 532153 RAINCALCIN
Rathi India Ltd 506959
Refnol Resins & Chemicals Ltd(Merged) 530815
Rencal Chemicals (India) Ltd 524510
Resonance Specialities Ltd 524218
Revati Organics Ltd 524504
Rhodia Specialty Chemicals India Ltd(Merged) 506230 ALBRMORARJ
Rite Zone Chemcon India Ltd 535489 RITEZONE
Ritesh International Ltd 519097
Rock Hard Petro Chemical Industries Ltd 524194
Rossari Biotech Ltd 543213 ROSSARI
Rukmani Metals & Gaseous Ltd 40695
S H Kelkar & Company Ltd 539450 SHK
S K R Chemicals Ltd 530371
Sadhana Nitro Chem Ltd 506642 SADHNANIQ
Salvigor Laboratories Ltd (Merged) 524268
Sanderson Industries Ltd 507728 SANDERIND
Sanginita Chemicals Ltd 538408 SANGINITA
Sarang Chemicals Ltd 532031
Searsole Chemicals Ltd (Wound-up) 506644
Seya Industries Ltd 524324 SEYAIND
Shaper Chemicals Ltd (Wound-up) 524566
Shayona Petrochem Ltd 531538
Shentracon Chemicals Ltd 530757
Shree Benzophen Industries Ltd 531389
Shree Neelachal Laboratories Ltd 531487
Shri Ambuja Petro Chemicals Ltd 506742
Shri Aster Silicates Ltd 533219 SHRIASTER
Shri Nicosect Ltd 526437
SI Group - India Ltd 506460 SIGROUPIND
SMZS Chemicals Ltd(wound-up) 524160 SMZSCHEM
Solar Industries India Ltd 532725 SOLARINDS
Sonal Sil Chem Ltd 524673
Southern Gas Ltd 509910
Speciality Petrolubes Ltd 523525
Sree Rayalaseema Hi-Strength Hypo Ltd 532842 SRHHYPOLTD
Sree Rayalaseema Petrochemicals Ltd (Merged) 524618
Sreechem Resins Ltd 514248
SRF Ltd 503806 SRF
SRHHL Industries Ltd (Merged) 524410 SRHHLINDST
Sterling Biotech Ltd 512299 STERLINBIO
Sudev Chemicals Ltd 40666
Sun Star Chemicals Ltd 524536 SUNSTRCHEM
Sunshield Chemicals Ltd 530845
Sunstar Lubricants Ltd 524452 SUNSTARLUB
Superior Air Products Ltd (Merged) 526469
Swarnajyothi Agrotech & Power Ltd 590090
Tamil Nadu Industrial Explosives Ltd 524028
Tamil Nadu Petro Products Ltd 500777 TNPETRO
Tanfac Industries Ltd 506854 TANFACIND
Tata Chemicals Ltd 500770 TATACHEM
Tatva Chintan Pharma Chem Ltd 543321 TATVA
TECIL Chemical & Hydro Power Ltd 506680 TECILCHEM
Tetrahedron Ltd 40308
Thirani Chemicals Ltd (Merged) 524125
Thirumalai Chemicals Ltd 500412 TIRUMALCHM
Tide Water Oil Co (I) Ltd 590005 TIDEWATER
Tirupati Inks Ltd 533258
Transpek Industry Ltd 506687 TRANSPEK
Tria Fine Chem Ltd 524721
Tribology India Ltd 40171
Trigon Zinco Ltd 530287
Tulasee Bio-Ethanol Ltd 524514
U P Lime Chem Ltd 524677
Unique Oils India Ltd 523250
Urvi Chemicals & Allied Industries Ltd 501371
Vadilal Chemicals Ltd 40485
Vadivarhe Speciality Chemicals Ltd 538429 VSCL
Valiant Organics Ltd 540145 VALIANTORG
VBC Industries Ltd 524310
Vibros Organics Ltd 530487
Vijayshree Chemicals (India) Ltd 524312
Vikas Wsp Ltd 519307 VIKASWSP
Vinati Organics Ltd 524200 VINATIORGA
Vishnu Chemicals Ltd 516072 VISHNU
Vision Organics Ltd 532383 VISIONLTD
Vital Chemtech Ltd 535490 VITAL
Yasho Industries Ltd 541167 YASHO
Yug Decor Ltd 540550

Share Holding

Category No. of shares Percentage
Total Foreign 1097282 8.43
Total Institutions 685536 5.27
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 236677 1.82
Total Promoters 7667156 58.88
Total Public & others 3334251 25.61
Total 13020902 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About Fairchem Organics Ltd

Fairchem Organics Limited was incorporated as a Public Limited Company on March 27, 2019. The Company is mainly in manufacturing of speciality chemicals like Oleo Chemicals and Intermediate Nutraceuticals. The manufacturing facility is set up at Village Chekhala, Ta. Sanand, Dist. Ahmedabad, Gujarat, India. Fairchem has perfected the business model of procuring waste generated in the oil refining mills and then using state of the art process equipment to isolate and purify a variety of components from the waste. Some of these components are used as building blocks to make further value-added products like Dimer acid. Fairchem is India's only manufacturer of Dimer acid used in many consumer products including paints, printing inks, epoxy hardeners, drilling chemicals and moulds. The Company also processes Tocopherol which is used in formulating Natural Vitamin-E. The Company tracks the import data from China as Chinese suppliers are main competitors for the Company. Based on analysis, the Company continues to maintain leadership position in Indian market by its pricing strategy, timely service, quick supply and fair terms of payment and quality product. Dimer Acid is a value added product of the Company which is derived as one of the streams by further processing Linoleic Acid. Dimer Acid is used for making two kinds of polyamides i.e. Non-reactive and reactive. Non-reactive polyamides are used by manufacturers of printing inks, adhesives, paper coatings etc. Rising demand from industries such as printing inks, adhesives and paper coatings may drive global dimer acid market size for non-reactive polyamide resins. The demand for Reactive polyamide resins application will be driven by increasing surface coatings & adhesives demand in marine and construction. The end use of both - Linoleic Acid and Soya Fatty Acid - is same i.e. for making Alkyd Resins which in turn is used in making paints. In 1996, the Company started producing mixed tocopherol concentrate. In 2002, the Company started making Dimer Acid and Monobasic Acid. In 2013, the raw material throughput capacity was increased to 18000 MTPA. In 2014, the raw material throughput capacity increased to 24000 MTPA and the Company undertook Capex to increase this capacity to 45000 MTPA. In 2016, the Company increased raw material capacity to 45000 MT. The Board of Directors of the Company, in its meeting held on May 22, 2019, had approved a Composite Scheme of Arrangement and Amalgamation amongst Fairchem Speciality Limited (FSL), Fairchem Organics Limited (FOL) and Privi Organics India Limited (POIL), two wholly owned subsidiaries of FSL and their respective shareholders for Demerger of FSL's undertaking carrying on speciality oleo chemicals and nutraceuticals business and vesting the same into FOL and Amalgamation of POIL, manufacturers of aroma chemicals, into and with FSL, under Sections 230 to 232 read with Section 66 and other applicable provisions of the Companies Act, 2013. National Company Law Tribunal (NCLT) has sanctioned the Scheme on June 30, 2020. The Company received Certified Copy of the Scheme on August 3, 2020. The said Scheme has been adopted by the Board of Directors of FSL, FOL and POIL in their meeting held on August 12, 2020. As a consequence, the Scheme has been made effective with effect from August 12, 2020. During the year 2020, the Company issued 1,30,20,902 Equity Shares of Rs. 10/- each fully paid up to shareholders of Fairchem Speciality Limited (FSL) on August 24, 2020. These Equity Shares were issued pursuant to the Order dated June 30, 2020 of Hon'ble N.C.L.T., Mumbai Bench, inter alia, sanctioning the Composite Scheme of Arrangement and Amalgamation between the Company, FSL and Privi Organics India Limited. Further, pursuant to the said Scheme, the then existing paid up equity share capital of Rs. 1,00,000/- held entirely by FSL and its nominees was cancelled. In 2021, the Company expanded raw material capacity from 45000 MTPA to 72000 MTPA.

Fairchem Organics Ltd Chairman Speech

What we achieved in the area of Vitamin D in the last decade is what we seek to achieve in the nutraceuticals space across the next ten years.

Overview

If there is a singular overarching message of this annual report, then it is this: ever since we remember we were told that food is important for our existence.

The time has come to add a prefix: the word ‘fortified’.

The increasing relevance of this word is derived from the fact that the world faces a large economic burden arising from malnutrition. India is ranked an alarming 102 out of 117 countries in the Global Hunger Index (GHI), a reflection of chronic and acute undernutrition. Malnutrition is the most common cause of immunodeficiency, with micronutrient deficiency and protein-energy malnutrition being at the core of the challenge.

The trinity of dietary diversification, food fortification and supplementation are required for overcoming micronutrient deficiency. Fermenta’s products enjoy extensive applications across supplementation and fortification, which play a large health role. Fortification of staple foods is being widely acknowledged as one of the most effective ways for combating micronutrient deficiency across age groups. The addition of micronutrient premix to food to enhance the nutritional quality is a scientifically proven, cost-effective, scalable and sustainable solution. In the last few years, there has been a greater impetus to the fortification movement. Forward-looking governments are recognising that the cost of proactive food fortification is but a fraction of the cost arising out of reactive remedial action, which could include the cost of medicines and hospitalisation. Following the pandemic, the inflection point is here and now. What years of advocacy barely achieved is now a global demand for increased immunity derived from balanced food consumption.

At Fermenta, we are prepared for this reality. The addressable market is large and growing: there is a multi-decade growth headroom available in this segment. We are investing long-term resources to address this opportunity. We believe that this business represents our new frontier; what we achieved in the area of Vitamin D in the last decade is what we seek to achieve in the nutraceuticals space across the next ten years. What provides me confidence and optimism is that we possess the vision, synergic capabilities, technological competence and operational discipline to make this happen. We are competently placed to provide the complete basket of products (either manufactured within or outsourced) that makes a single-point solution provider. What we have going for our business case is that we are prudently borrowing, we have a widening global presence through subsidiaries, our manufacturing discipline has been validated by demanding global customers and certifications and we have demonstrated the capacity to build and sustain eco-system relationships across the long-term.

The result is that we are not just engaged in growing our business from quarter to quarter; we are engaged in capitalising on a structural shift with a fundamental change in the way we see our business across the coming decade. We expect to address this sizable opportunity with a prudent mix of debt and internal accruals, which are intended to enhance value in the hands of all those who own shares in our Company.

Mr. Sanjay Buch

Chairman

   

Fairchem Organics Ltd Company History

Fairchem Organics Limited was incorporated as a Public Limited Company on March 27, 2019. The Company is mainly in manufacturing of speciality chemicals like Oleo Chemicals and Intermediate Nutraceuticals. The manufacturing facility is set up at Village Chekhala, Ta. Sanand, Dist. Ahmedabad, Gujarat, India. Fairchem has perfected the business model of procuring waste generated in the oil refining mills and then using state of the art process equipment to isolate and purify a variety of components from the waste. Some of these components are used as building blocks to make further value-added products like Dimer acid. Fairchem is India's only manufacturer of Dimer acid used in many consumer products including paints, printing inks, epoxy hardeners, drilling chemicals and moulds. The Company also processes Tocopherol which is used in formulating Natural Vitamin-E. The Company tracks the import data from China as Chinese suppliers are main competitors for the Company. Based on analysis, the Company continues to maintain leadership position in Indian market by its pricing strategy, timely service, quick supply and fair terms of payment and quality product. Dimer Acid is a value added product of the Company which is derived as one of the streams by further processing Linoleic Acid. Dimer Acid is used for making two kinds of polyamides i.e. Non-reactive and reactive. Non-reactive polyamides are used by manufacturers of printing inks, adhesives, paper coatings etc. Rising demand from industries such as printing inks, adhesives and paper coatings may drive global dimer acid market size for non-reactive polyamide resins. The demand for Reactive polyamide resins application will be driven by increasing surface coatings & adhesives demand in marine and construction. The end use of both - Linoleic Acid and Soya Fatty Acid - is same i.e. for making Alkyd Resins which in turn is used in making paints. In 1996, the Company started producing mixed tocopherol concentrate. In 2002, the Company started making Dimer Acid and Monobasic Acid. In 2013, the raw material throughput capacity was increased to 18000 MTPA. In 2014, the raw material throughput capacity increased to 24000 MTPA and the Company undertook Capex to increase this capacity to 45000 MTPA. In 2016, the Company increased raw material capacity to 45000 MT. The Board of Directors of the Company, in its meeting held on May 22, 2019, had approved a Composite Scheme of Arrangement and Amalgamation amongst Fairchem Speciality Limited (FSL), Fairchem Organics Limited (FOL) and Privi Organics India Limited (POIL), two wholly owned subsidiaries of FSL and their respective shareholders for Demerger of FSL's undertaking carrying on speciality oleo chemicals and nutraceuticals business and vesting the same into FOL and Amalgamation of POIL, manufacturers of aroma chemicals, into and with FSL, under Sections 230 to 232 read with Section 66 and other applicable provisions of the Companies Act, 2013. National Company Law Tribunal (NCLT) has sanctioned the Scheme on June 30, 2020. The Company received Certified Copy of the Scheme on August 3, 2020. The said Scheme has been adopted by the Board of Directors of FSL, FOL and POIL in their meeting held on August 12, 2020. As a consequence, the Scheme has been made effective with effect from August 12, 2020. During the year 2020, the Company issued 1,30,20,902 Equity Shares of Rs. 10/- each fully paid up to shareholders of Fairchem Speciality Limited (FSL) on August 24, 2020. These Equity Shares were issued pursuant to the Order dated June 30, 2020 of Hon'ble N.C.L.T., Mumbai Bench, inter alia, sanctioning the Composite Scheme of Arrangement and Amalgamation between the Company, FSL and Privi Organics India Limited. Further, pursuant to the said Scheme, the then existing paid up equity share capital of Rs. 1,00,000/- held entirely by FSL and its nominees was cancelled. In 2021, the Company expanded raw material capacity from 45000 MTPA to 72000 MTPA.

Fairchem Organics Ltd Directors Reports

To

The Members,

Your Directors are indeed pleased to present the Fourth Annual Report along with Audited financial statements of the Company for the financial year ended March 31, 2023. These financial statements have been prepared in accordance with Indian Accounting Standards (Ind-AS) as required under The Companies Act, 2013.

FINANCIAL RESULTS:

(Rupees in Lakhs, unless otherwise stated)

Z For the year ended on 31-03-2023 For the year ended on 31-03-2022
(1) Total Income 64,871.66 64,354.60
(2) Profit before Interest, Depreciation and Tax 7,300.68 10,522.69
(3) Less : Interest 626.24 685.55
(4) Profit before Depreciation and Tax 6,674.44 9,837.14
(5) Less : Depreciation 815.19 713.10
(6) Profit before Tax for the year 5,859.25 9,124.04
(7) Less : Provision for Taxation
(a) Current Tax 1,349.64 2,190.15
(b) Deferred tax 159.46 143.25
Sub-total 1,509.10 2,333.40
(8) Profit after Tax for the year 4,350.15 6,790.64
(9) Add : Other comprehensive income for the year / period, net of tax 53.62 6.60
(10) Total Comprehensive Income for the year / period 4,403.77 6,797.24
(11) Earnings per share (EPS) of Rs. 10/- each Rs. 33.41 Rs. 52.15

OPERATIONS AND THE STATE OF COMPANY'S AFFAIRS:

During the year under review, the revenue from operations were Rs. 64,804.10 lakhs, which is nearly flat. The Profit before tax stood at Rs. 5,859.25 lakhs, which is sharply lower by about 35.78 %. This performance needs to be evaluated considering the relatively weaker second and third quarters. The silver lining in the annual performance is equally sharp revival during January March, 2023 quarter over immediately preceding quarter.

CHANGE IN NATURE OF BUSINESS:

There is no change in the nature of business of the Company during the year.

DIVIDEND:

Your Directors are pleased to recommend a dividend of Rs. 7.50 (i.e. 75%) per equity share for the financial year ended March 31, 2023, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. Dividend will be paid to those shareholders whose names appear in the Register of Members as on Book Closure / Record Date to be fixed by the Company.

The Company has formulated Dividend Distribution Policy in compliance with Regulation 43A of SEBI (LODR) Regulations, 2015. The Dividend Distribution policy is placed on the Website of the Company at https://www.fairchem.in/investor-relations/ Policies/Dividend-Distribution-Policy.pdf

Pursuant to the Scheme of Arrangement and Amalgamation between FAIRCHEM SPECIALITY LIMITED (FSL) (‘Demerged Company' / ‘Transferee Company') (Now known as PRIVI SPECIALITY CHEMICALS LIMITED) AND FAIRCHEM ORGANICS LIMITED (FOL) ‘Resulting Company') AND PRIVI ORGANICS INDIA LIMITED (‘Transferor Company') AND their respective Shareholders, all the assets and liabilities of Demerged Undertaking of the Demerged Company were transferred to Resulting Company. Accordingly, along with Rsall' the assets and liabilities, four banking accounts, being Unpaid Dividend accounts for the financial years 2015-16, 2016-17, 2017-18 and 2018-19 along with corresponding liability of Equity Dividend Payable for each of the years were also transferred from the books of erstwhile FSL to the books of FOL.

Pursuant to the provisions of The Companies Act, 2013 and / or Rules made thereunder, such unpaid dividend accounts need to be carried in the books for seven years. As the RsCompany' FSL (whose name was subsequently changed to Privi Speciality Chemicals Limited RsPSCL') is under the management of Privi group, the periodical compliance under all applicable laws including the Company Law in respect of the above accounts is to be done by the said PSCL. In view of this, after taking the consent of the Boards of both the companies, the above banking accounts, being the assets along with corresponding liabilities have been transferred from the books of FOL to the books of PSCL as at March 31, 2023. This transfer per se does not impact the net worth of any of the companies.

TRANSFER TO RESERVE:

Your Directors have decided not to transfer any amount to the Reserve for the year under review.

MATERIAL CHANGES AND COMMITMENTS:

There have been no material changes and commitments which have occurred between the end of the financial year to which the financial statements relate and the date of this Report, affecting the financial position of the company.

CAPITAL STRUCTURE:

The Company has only one class of Equity Shares having equal voting rights. The present issued, subscribed and paid up share capital of the Company is Rs. 13,02,09,020/- divided into 1,30,20,902 Equity Shares of Rs. 10/- each fully paid up. There is no change in the Capital structure of the Company during the year.

IMPACT OF COVID-19 PANDEMIC:

Health scares due to COVID-19 Pandemic had resulted in global economic disruption for an extended period of nearly 2 years over its various phases. However, due to robust vaccination programmes, particularly by countries with large population, the pandemic could be controlled to a substantial extent. The Company was not directly adversely impacted due to this pandemic during the year under review.

SIGNIFICANT EVENT DURING THE YEAR UNDER REVIEW:

BSE Limited and National Stock Exchange of India Limited, vide their letters dated February 27, 2023, had approved the application for reclassification of 17 applicants of Privi Group from “Promoter” to “Public”.

MEETINGS OF THE BOARD:

During the Financial Year 2022-23, 4 (four) meetings of the Board of Directors took place at which sufficient quorum was present throughout all the meetings. In respect of these meetings, proper notices were given, and the proceedings were properly recorded and signed in the Minutes Book maintained for the purpose. For further details, please refer Report on Corporate Governance.

PARTICULARS OF LOANS GUARANTEES AND INVESTMENTS:

The Company has not given any loan, made investment, given any guarantee or provided any security to the persons covered u/s. 186 of the Companies Act, 2013.

CORPORATE GOVERNANCE, MANAGEMENT DISCUSSION AND ANALYSIS REPORT AND BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT:

A Report on the Corporate Governance along with a certificate from a practicing Company Secretary regarding the compliance of conditions of Corporate Governance as stipulated in Regulation 34(3) of SEBI (LODR) Regulations, 2015 read with Schedule V of the said regulations and the Management Discussion and Analysis Report are attached as a separate section of this Annual Report.

Pursuant to Regulation 34(2)(f) of the Listing Regulations as amended from time to time, the Business Responsibility and Sustainability Report (‘BRSR') and initiatives taken from an environmental, social and governance perspective in the prescribed format is attached as a separate section of this Annual Report.

AUDIT COMMITTEE:

The Audit Committee of the Company is duly constituted in compliance with Regulation 18 of SEBI (LODR) Regulations 2015. The Composition of Audit Committee is given in the Corporate Governance Report forming part of this Report.

DEPOSITS:

The Company has not accepted nor renewed any deposits falling within the ambit of Section 73 of the Companies Act, 2013 and The Companies (Acceptance of Deposits) Rules, 2014.

CREDIT RATING:

CARE Ratings Limited carried out annual review of credit facilities of HDFC Bank and vide its letter dated August 12, 2022, has assigned/reaffirmed its rating as under: 1. For Long-term Bank facilities: CARE A+; Stable (Single A Plus; Outlook Stable) 2. For Long-term / Short term Bank facilities: CARE A+; Stable / CARE A1+ (Single A Plus; Outlook: Stable / A One Plus) 3. Short Term Bank facilities: CARE A1+ (A One Plus)

INVESTOR EDUCATION AND PROTECTION FUND (IEPF):

The Company was incorporated during 2019 and has not completed period of seven years. Hence, the provisions of Companies Act, 2013 read with Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 (“IEPF Rules”) which provides that all unclaimed dividends are required to be transferred by the Company to the IEPF, after completion of seven (7) years, are not applicable. Further, according to IEPF Rules, the shares on which dividend has not been claimed by the shareholders for seven (7) consecutive years or more shall be transferred to the demat account of the IEPF Authority. As this is only the fourth financial year of the Company, this provision is also not applicable to the Company.

TECHNICAL ACHIEVEMENT:

The Company keeps on exploring the possibility of technical improvement and process optimization for better yields / product mix / energy efficiency.

DIRECTORS:

In accordance with the provisions of Section 152 of the Act, Shri Nahoosh Jariwala (DIN: 00012412) shall retire at the forthcoming Annual General Meeting of the Company and being eligible, has offered himself for re-appointment. The tenure of Shri Nahoosh Jariwala as Managing Director of the Company, will come to an end on August 12, 2023 and hence, the Board of Directors, upon the recommendation of the Nomination and Remuneration Committee, had re-appointed Shri Nahoosh Jariwala for a further period of three years w.e.f. August 13, 2023 to August 12, 2026, subject to approval of the members at the ensuing Annual General Meeting of the Company.

Shri Utkarsh Shah, one of the Promoters of the Company, post his resignation as Director, has applied for reclassification of his status from ‘Promoter' to ‘Public' category of the Company pursuant to Regulation 31A of SEBI (LODR) Regulations, 2015, which was approved by the Board of Directors in their Meeting held on 28.03.2022. The Company has then submitted the application to both the Stock Exchanges for reclassification of his status from ‘Promoter' to ‘Public' category of the Company.

Thereafter, due to sudden demise of Shri Utkarsh Shah on 22.08.2022, 23,333 Equity Shares held in the sole name of Shri Utkarsh Shah were transmitted in favour of Shri Aadarsh Shah (first holder) and Mrs. Radhika Shah (joint holder) on 08.09.2022 and as per SEBI Regulations, they have now become the promoters of the Company. Based on the application by them, the Company has applied to both the Stock Exchanges for their re-classification to ‘Public' category. The application, as on date, is under process.

DECLARATION OF INDEPENDENCE GIVEN BY INDEPENDENT DIRECTORS:

The Company has received declarations from all the 4 Independent Directors of the Company, inter alia, confirming that they meet the criteria of Independence and that they are not disqualified for continuing as an Independent Director as prescribed under Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of SEBI (LODR) Regulations, 2015, as amended, respectively.

COMPANY'S POLICY ON DIRECTORS' APPOINTMENT AND REMUNERATION INCLUDING CRITERIA FOR DETERMINING QUALIFICATIONS, POSITIVE ATTRIBUTES, INDEPENDENCE OF A DIRECTOR ETC.:

Pursuant to the provisions of Section 178 and other applicable provisions, if any, of the Companies Act, 2013 read with the Rules made thereunder and Regulation 19 of SEBI (LODR) Regulation, 2015, the Board of Directors at their Meeting held on 12.08.2020 approved the Nomination and Remuneration Policy. The salient features of the said policy covering the policy on appointment and remuneration and other matters have been explained in the Corporate Governance Report. Copy of Nomination and Remuneration Policy of the Company can be accessed from the website of the Company https:/ /www.fairchem.in/investor-relations/Policies/Nomination-&-Remuneration-Policy-FOL.pdf

BOARD EVALUATION:

Based on the criteria for evaluation of Independent Directors and the Board as recommended by the Nomination and Remuneration Committee and as adopted by the Board, Board carried out evaluation of its own performance, the individual Directors and the Committees. The evaluation of Independent Directors, as provided in Regulation 17 (10) of Listing Regulations, was done by the Board which included their performance and fulfillment of independence criteria as specified in Listing Regulations and their independence from the management.

The Independent Directors reviewed the performance of (1) Non-Independent Directors and Board as a whole and (2) the Chairman of the Company, taking into account the views of the Managing Director and Non-executive non-independent Director in their separate meeting held on March 10, 2023. They expressed their satisfaction with the performance of Non-Independent Directors and Board as a whole and also of the Chairman of the Board.

DIRECTORS' RESPONSIBILITY STATEMENT:

Pursuant to the requirement of Section 134(3)(c) of the Companies Act, 2013 and to the best of their knowledge and belief, and according to the information and explanations provided to them, your Directors hereby make the following statements: (i) that in the preparation of the financial statements for the year ended March 31, 2023, the applicable accounting standards read with requirements set out under Schedule III of the Companies Act have been followed and there are no material departures from the same; (ii) that the Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year viz. March 31, 2023 and of the profit of the Company for that period; (iii) that the Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; (iv) that the Directors have prepared the annual accounts on a ‘Going Concern' basis; (v) that the Directors have laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively and (vi) that the Directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.

LISTING:

The securities of the Company are listed with BSE Limited and National Stock Exchange of India Limited with effect from December 24, 2020. SEBI (LODR) Regulations, 2015 became applicable to the Company from the said date. The Company has paid the listing fees for F.Y. 2023-24 on the paid up equity share capital to both the Stock Exchanges.

CONTRACTS AND ARRANGEMENTS WITH RELATED PARTIES:

All contracts / arrangements / transactions with related parties entered into by the Company during the financial year were in the ordinary course of business and on an arm's length basis. During the year, the Company had not entered into any contract / arrangement / transaction with related parties which could be considered material as described under the Regulation 23(1) of SEBI (LODR) Regulations 2015.

The policy on Related Party Transactions as approved by the Board is uploaded on the Company's website. Copy of Policy on Related Party Transactions can be accessed from the website of the Company https://www.fairchem.in/investor-relations/ Policies/Related-Party-Transactions-Policy-FOL.pdf

INTERNAL CONTROL AND ITS ADEQUACY:

The Company has, commensurate with its size, single operational location and resultant requirement, Internal Control system. A well-known firm of Chartered Accountants carried out internal audit of the said system. Based on the recommendation / report of the said Internal Auditors which are presented to the Audit Committee, required corrective actions were initiated / taken by the Company.

INTERNAL FINANCIAL CONTROLS:

The Directors have laid down policies and procedures which are adopted by the Company for ensuring the orderly and efficient conduct of its business, including adherence to Company‘s policies, the safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial information;

FRAUD:

During the year under review, no fraud was reported by the statutory auditors under section 143(12) of the Act.

CORPORATE SOCIAL RESPONSIBILITY:

The Board had approved Corporate Social Responsibility Policy in its meeting held on 12.08.2020. The copy of Corporate Social Responsibility Policy is placed on the website of the Company at https://www.fairchem.in/investor-relations/Policies/ CSR-Policy-FOL.pdf.

The Corporate Social Responsibility Committee of the Board is duly constituted in compliance with provisions of Section 135 of Companies Act 2013. The Committee comprises of 1. Shri Nahoosh Jariwala 2. Shri Sumit Maheshwari 3. Ms. Sonal Ambani The other details of the CSR activities as required U/s. 135 of The Companies Act, 2013 are given in the CSR Report as Annexure A to Directors' Report.

PARTICULARS OF EMPLOYEES:

Details pertaining to remuneration as required under Section 197(12) of the Companies Act, 2013 read with Rule 5(1) and 5(2) of Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are provided under Annexure B to this Directors' Report.

RISK MANAGEMENT POLICY:

The Company has put in place Risk Management Policy and Plan. The Company has identified (i) Business Risk (ii) Technological Risk (iii) Financial Risk (iv) Liquidity Risk (v) Exchange Rate Risk (v) Country specific Risk (vi) Safety Risk (vii) Employee Risk and (viii) Risk of Natural Calamities which in the opinion of the Board may threaten the existence of the Company.

The team of top 3 officials of the Company under the supervision and guidance of the Managing Director monitor the above mentioned or any other unforeseen / unexpected risks and ensure the smooth and clinical implementation of mitigation measures as outlined in the plan and / or as are in the best interest of the company under the circumstances.

STATUTORY AUDIT REPORT:

The auditors M/s. B S R & Co. LLP, Chartered Accountants LLP were appointed at the 1st Annual General Meeting held on December 31, 2020 for a term of five years, from the conclusion of first AGM till the conclusion of sixth AGM to be held in the year 2025. The Auditors' report during the year under review does not contain any qualification/ remarks nor any instance of fraud committed against the Company by its officers or employees, the details of which would need to be mentioned in the Board's report.

SECRETARIAL AUDIT REPORT:

As required by Section 204 of The Companies Act, 2013 read with The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Board has appointed M/s. Parikh Dave & Associates, Company Secretaries, Ahmedabad, a peer reviewed firm of Company Secretaries in Practice to conduct Secretarial Audit for the Financial Year 2022-23. The Report of the Secretarial Audit for the financial year ended on March 31, 2023 is enclosed as Annexure C to this Directors' Report.

The Secretarial Audit Report of the Company for the F.Y. 2022-23 is qualified with following observation

As mandated under provision of Regulation 19 and 20 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, no meeting of Nomination and Remuneration Committee and Stakeholders Relationship Committee respectively was held.

During the year under review, conduct of meetings of Nomination and Remuneration Committee & Stakeholders Relationship Committee were inadvertently missed out. The Company will conduct such meetings during the year 2023-24 and will be more cautious in future.

CONFIRMATION OF COMPLIANCE OF SECRETARIAL STANDARDS:

During the year under review, the Company has complied with the applicable Secretarial Standards i.e. SS-1 and SS-2, relating to “Meetings of the Board of Directors” and “General Meetings”, respectively, issued by The Institute of Company Secretaries of India (ICSI). The Company confirms compliances of applicable secretarial standards.

MAINTENANCE OF COST RECORDS:

As per the Companies (Cost Records and Audit) Rules, 2014 as amended by Companies (Cost Records and Audit) Amendment Rules, 2014, issued by the Central Government, the Company is required to get its cost records maintained by it for the products covered under Chapters 2917 and 3823 of Sr. No. 18 of table mentioned under Rule 3 (B) Non-regulated Sectors audited by a Cost Auditor.

As specified by the Central Government under sub-section (1) of section 148 of the Companies Act, 2013, the Company has maintained cost accounts and records.

COST AUDITOR:

The Company had appointed M/s. Rajendra Patel and Associates, as Cost Auditors for financial year 2022-23. The Board of Directors has approved their appointment as Cost Auditor for F.Y. 2023-24 also and has recommended remuneration of Rs. 75,000/- plus applicable tax. The necessary resolution for ratification of their remuneration by members has been put in the notice convening the 4th Annual General Meeting.

VIGIL MECHANISM:

As required under Companies Act and SEBI (LODR) Regulations, the Company has put in place Vigil Mechanism / Whistle Blower Policy for Directors and Employees so that the Directors and employees can report concerns about unethical behavior, actual or suspected fraud or violation of the Company's Code of Conduct Policy and SEBI Insider Trading

Regulations. Whistle Blower Policy is disclosed on the website: http://fairchem.in/investor-relations/Policies/Whistle-Blower-Policy.pdf

POLICY ON PREVENTION, PROHIBITION AND REDRESSAL OF SEXUAL HARASSMENT AT WORKPLACE:

Company has constituted Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 (Act). There is no female employee on the payroll of the Company itself. The Company, therefore, has appointed a woman employee under the contract as the Presiding Officer to comply with the requirement of the Act.

Company has framed a policy on Sexual Harassment at workplace which aims to provide protection to women employees at workplace and prevent and redress complaints of sexual harassment and for matters connected therewith or incidental thereto, with the objective of providing a safe working environment, where employees feel secure.

The Company has not received any complaint under the Sexual Harassment of women at Workplace during the financial year under review.

DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED:

No significant and material orders were passed during the year under review by regulators or courts, or tribunals impacting the going concern status and Company's operations in future,

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO:

(Initiatives of the Company for Energy conservation, and Technology absorption, if any and details of Foreign Exchange earnings and out go).

(A) Conservation of energy-

(i) The steps taken or impact on conservation of energy:

Based on an internal / external energy audit which is a regular periodical feature, required measures are taken for optimization of energy.

(ii) the steps taken by the company for utilising alternate sources of energy : None. (iii) the capital investment on energy conservation equipment : None.

(B) Technology absorption :

(i) the efforts made towards technology absorption:

Technology absorption is an ongoing process in the Company. The Company keeps on exploring new processes at Laboratory scale and then implements the same at Plant level.

(ii) the benefits derived like product improvement, cost reduction, product development or import substitution: The Company continuously works on increasing yield of prime products which helps in overall cost reduction. (iii) in case of imported technology (imported during the last three years reckoned from the beginning of the financial year): (a) the details of technology imported: Nil (b) the year of import: Not Applicable (c) whether the technology been fully absorbed: Not Applicable (d) if not fully absorbed, areas where absorption has not taken place, and the reasons thereof: Not Applicable (iv) the expenditure incurred on Research and Development: Rs. 19.48 Lakhs.

C. Foreign exchange earnings and Outgo :

Foreign Exchange Earnings : Rs. 2,668.84 lakhs
Foreign Exchange Outgo : Rs. 3,304.67 lakhs

DETAILS OF SUBSIDIARY, JOINT VENTURE, ASSOCIATE COMPANY:

The Company does not have any subsidiary company or associate company. Company has not entered into any joint venture. Hence, no further disclosures are required in this regard.

EXTRACT OF ANNUAL RETURN:

As per the provisions of section 92(3) read with section 134(3)(a) of the Act, the Annual Return as on March 31, 2023 in the prescribed form no. MGT-7 is available on the website of the Company and web link of the same is https://www.fairchem.in/ investor-relations-fol.html - Annual Reports.

GENERAL DISCLOSURE

Your Directors state that no disclosure or reporting is required in respect of the following items as there were no transactions/ instances on these items during the year under review:

1. Issue of equity shares with differential rights as to dividend, voting or otherwise.

2. Issue of Shares (including Sweat Equity Shares) to employees of the Company under any scheme.

3. Voting rights which are not directly exercised by the employees in respect of shares for the subscription/purchase of which loan was given by the Company (as there is no scheme pursuant to which such persons can beneficially hold shares as envisaged under section 67(3)(c) of the Companies Act, 2013).

4. Application made or any proceeding pending under the Insolvency and Bankruptcy Code, 2016.

5. One time settlement of loan obtained from the Banks or Financial Institutions.

ACKNOWLEDGMENTS:

Your Board of Directors wishes to place on record its appreciation to the contribution made by the employees of the Company. The Company was able to hold on to its share on the domestic market for two prime products during the year through the competence, hard work, solidarity, cooperation and support of employees at all levels. The Directors also wish to thank the Company's vendors, Stock Exchanges, Government authorities, bank and shareholders for their cooperation and assistance extended to the Company.

For and on behalf of the Board of Directors,
Nahoosh Jariwala
Place : Chekhala, Tal. Sanand, Dist. Ahmedabad Chairman and Managing Director
Date : May 30, 2023 (DIN : 00012412)

   

Fairchem Organics Ltd Company Background

Nahoosh J JariwalaNahoosh J Jariwala
Incorporation Year2019
Registered OfficePlot No A-71 TTC Indl Estate,Near Thane Belapur Road
Mumbai,Maharashtra-400709
Telephone91-9016324095 / 9409958550,Managing Director
Fax
Company SecretaryRajen Niranjanbhai Jhaveri
AuditorB S R & Co LLP
Face Value10
Market Lot1
ListingBSE,NSE,
RegistrarLink Intime India Pvt Ltd
5th Floor 506 to 508,ABC-I Off C G Road ,Navrangpura ,Ahmedabad-380009

Fairchem Organics Ltd Company Management

Director NameDirector DesignationYear
Nahoosh J JariwalaChairman & Managing Director2023
Venkatraman SrinivasanIndependent Director2023
Darius Dinshaw PandoleIndependent Director2023
Sonal AmbaniIndependent Director2023
Sumit MaheshwariNominee2023
Rajen Niranjanbhai JhaveriCompany Sec. & Compli. Officer2023
Sudhin ChokseyIndependent Director2023

Fairchem Organics Ltd Listing Information

Listing Information
BSESMALLCA
BSEALLCAP
BSEMETERIA

Fairchem Organics Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
UnspecifiedNA0000

Contact us Contact us